Key facts
| Price (PPV) | 51 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | méloxicam |
| Class | Antiinflammatory and antirheumatic products |
| ATC code | M01AC06 |
| Manufacturer | IBERMA |
| Presentation | Boite de 20 |
| Hospital price | 31.90 MAD |
| Data collected on | 9/8/2026 |
Indications
Le méloxicam est utilisé pour réduire l’inflammation et la douleur dans les articulations et les muscles. Il est indiqué chez l’adulte et l’enfant âgé de 16 ans et plus. MELOXICAM est utilisé dans les cas suivants : - traitement de courte durée des douleurs aiguës d'arthrose ; - traitement de longue durée : de la polyarthrite rhumatoïde et de la spondylarthrite ankylosante.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 16 other products contain the same active substance as Ibermox 7.5 mg (Méloxicam), at the same strength and in the same dosage form. For the same pack size (Boite de 20), the cheapest is Aflamic 7.5 mg (DEVA PHARMACEUTIQUE) at 46.70 MAD, i.e. 8 % less than Ibermox 7.5 mg (51 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Aflamic 7.5 mg | DEVA PHARMACEUTIQUE | Boite de 20 | 46.70 MAD | 2.34 / unit | −8 % |
| Melicam Ipharma 7.5 mg | SPIMACO | Boite de 20 | 47.70 MAD | 2.39 / unit | −6 % |
| Artyx 7.5 mg | MC PHARMA | Boite de 20 | 49.70 MAD | 2.49 / unit | −3 % |
| Zenoxia 7.5 mg | ZENITH PHARMA | Boite de 20 | 49.70 MAD | 2.49 / unit | −3 % |
| Mefsal 7.5 mg | COOPER PHARMA | Boite de 20 | 51 MAD | 2.55 / unit | — |
| Meloxicam GT 7.5 mg | ATLAS PHARM | Boite de 20 | 51 MAD | 2.55 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Aflamic 7.5 mg | DEVA PHARMACEUTIQUE | Boite de 10 | 26.20 MAD | 2.62 / unit |
| Artyx 7.5 mg | MC PHARMA | Boite de 10 | 27.10 MAD | 2.71 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Ibermox 7.5 mg
Ibermox 7.5 mg belongs to the antiinflammatory and antirheumatic products therapeutic class. In Morocco, this drug is marketed by IBERMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Ibermox 7.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Ibermox 7.5 mg
Answers to common questions from Moroccan patients about this drug.